Shionogi (Pharmaceutical Brands) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
- Investments
-
3
Shionogi (Pharmaceutical Brands) General Information
Description
Portfolio of four pharmaceutical brands. The portfolio includes four brand pharmaceutical products Triglide Tablets, Robinul and Robinul Forte Tablets, Furadantin Suspension and Fexmid Tablets.
Contact Information
Corporate Office
- 3-1-8 Doshomachi
- Chuo-Ku
- Osaka, 541-0045
- Japan
Corporate Office
- 3-1-8 Doshomachi
- Chuo-Ku
- Osaka, 541-0045
- Japan
Shionogi (Pharmaceutical Brands) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Shionogi (Pharmaceutical Brands) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Shionogi (Pharmaceutical Brands) Investments (3)
Shionogi (Pharmaceutical Brands)’s most recent deal was a Later Stage VC with Reborna Biosciences for . The deal was made on 25-May-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Reborna Biosciences | 25-May-2023 | Later Stage VC | Drug Discovery | ||
| Reborna Biosciences | 14-Oct-2021 | Later Stage VC | Drug Discovery | ||
| Avita | 07-Sep-2021 | Seed Round | IT Consulting and Outsourcing |
Shionogi (Pharmaceutical Brands) Exits (2)
Shionogi (Pharmaceutical Brands)’s most recent exit was on 25-May-2023 from Reborna Biosciences. The exit was categorized as with 4 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Reborna Biosciences | 25-May-2023 | Completed |
|
||
| Reborna Biosciences | 14-Oct-2021 | Later Stage VC | Completed |
Shionogi (Pharmaceutical Brands) FAQs
-
Where is Shionogi (Pharmaceutical Brands) headquartered?
Shionogi (Pharmaceutical Brands) is headquartered in Osaka, Japan.
-
What industry is Shionogi (Pharmaceutical Brands) in?
Shionogi (Pharmaceutical Brands)’s primary industry is Buildings and Property.
-
Is Shionogi (Pharmaceutical Brands) a private or public company?
Shionogi (Pharmaceutical Brands) is a Private company.
-
What is Shionogi (Pharmaceutical Brands)’s current revenue?
The current revenue for Shionogi (Pharmaceutical Brands) is .
-
Who are Shionogi (Pharmaceutical Brands)’s investors?
Shionogi has invested in Shionogi (Pharmaceutical Brands).
-
When was Shionogi (Pharmaceutical Brands) acquired?
Shionogi (Pharmaceutical Brands) was acquired on 08-Jan-2016.
-
Who acquired Shionogi (Pharmaceutical Brands)?
Shionogi (Pharmaceutical Brands) was acquired by Casper Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process